Compare JVA & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JVA | CTSO |
|---|---|---|
| Founded | 1971 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2M | 23.9M |
| IPO Year | 1997 | 2008 |
| Metric | JVA | CTSO |
|---|---|---|
| Price | $4.11 | $5.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 62.5K | ★ 375.2K |
| Earning Date | 06-12-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | N/A | ★ 65.79 |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $90,655,294.00 | $22,503,908.00 |
| Revenue This Year | N/A | $10.34 |
| Revenue Next Year | N/A | $22.41 |
| P/E Ratio | $6.18 | ★ N/A |
| Revenue Growth | 17.54 | ★ 48.53 |
| 52 Week Low | $2.93 | $0.30 |
| 52 Week High | $5.26 | $7.44 |
| Indicator | JVA | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 70.91 | 80.82 |
| Support Level | $3.95 | $0.48 |
| Resistance Level | $4.16 | $7.44 |
| Average True Range (ATR) | 0.14 | 0.35 |
| MACD | 0.08 | 0.31 |
| Stochastic Oscillator | 83.40 | 78.40 |
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.